Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0005783 | endoplasmic reticulum | 5 | 2 |
GO:0016020 | membrane | 2 | 11 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: Q4QDW1
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 11 |
GO:0006644 | phospholipid metabolic process | 4 | 11 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 6 | 2 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 2 |
GO:0006793 | phosphorus metabolic process | 3 | 11 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0008610 | lipid biosynthetic process | 4 | 11 |
GO:0008654 | phospholipid biosynthetic process | 5 | 11 |
GO:0009058 | biosynthetic process | 2 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0019637 | organophosphate metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044249 | cellular biosynthetic process | 3 | 2 |
GO:0044255 | cellular lipid metabolic process | 3 | 11 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 2 |
GO:0046337 | phosphatidylethanolamine metabolic process | 6 | 2 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 2 |
GO:0046486 | glycerolipid metabolic process | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090407 | organophosphate biosynthetic process | 4 | 11 |
GO:1901576 | organic substance biosynthetic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004307 | ethanolaminephosphotransferase activity | 6 | 6 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 11 |
GO:0016780 | phosphotransferase activity, for other substituted phosphate groups | 4 | 11 |
GO:0017169 | CDP-alcohol phosphatidyltransferase activity | 5 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 134 | 138 | PF00656 | 0.482 |
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.282 |
CLV_NRD_NRD_1 | 258 | 260 | PF00675 | 0.581 |
CLV_NRD_NRD_1 | 283 | 285 | PF00675 | 0.360 |
CLV_NRD_NRD_1 | 410 | 412 | PF00675 | 0.576 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.282 |
CLV_PCSK_KEX2_1 | 258 | 260 | PF00082 | 0.610 |
CLV_PCSK_KEX2_1 | 283 | 285 | PF00082 | 0.319 |
CLV_PCSK_KEX2_1 | 410 | 412 | PF00082 | 0.528 |
CLV_PCSK_SKI1_1 | 201 | 205 | PF00082 | 0.304 |
CLV_PCSK_SKI1_1 | 209 | 213 | PF00082 | 0.364 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.537 |
DEG_SCF_FBW7_1 | 107 | 112 | PF00400 | 0.307 |
DEG_SCF_FBW7_1 | 15 | 22 | PF00400 | 0.685 |
DEG_SPOP_SBC_1 | 343 | 347 | PF00917 | 0.355 |
DOC_AGCK_PIF_2 | 34 | 39 | PF00069 | 0.628 |
DOC_CKS1_1 | 106 | 111 | PF01111 | 0.393 |
DOC_CKS1_1 | 16 | 21 | PF01111 | 0.663 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 113 | 122 | PF00134 | 0.219 |
DOC_MAPK_FxFP_2 | 332 | 335 | PF00069 | 0.348 |
DOC_MAPK_gen_1 | 258 | 268 | PF00069 | 0.339 |
DOC_PP2B_LxvP_1 | 97 | 100 | PF13499 | 0.426 |
DOC_PP4_FxxP_1 | 113 | 116 | PF00568 | 0.362 |
DOC_PP4_FxxP_1 | 332 | 335 | PF00568 | 0.348 |
DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.561 |
DOC_USP7_MATH_1 | 231 | 235 | PF00917 | 0.447 |
DOC_USP7_MATH_1 | 249 | 253 | PF00917 | 0.369 |
DOC_USP7_MATH_1 | 320 | 324 | PF00917 | 0.439 |
DOC_USP7_MATH_1 | 343 | 347 | PF00917 | 0.355 |
DOC_USP7_MATH_1 | 378 | 382 | PF00917 | 0.382 |
DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.670 |
DOC_WW_Pin1_4 | 100 | 105 | PF00397 | 0.371 |
DOC_WW_Pin1_4 | 112 | 117 | PF00397 | 0.298 |
DOC_WW_Pin1_4 | 15 | 20 | PF00397 | 0.582 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.586 |
LIG_14-3-3_CanoR_1 | 209 | 214 | PF00244 | 0.537 |
LIG_14-3-3_CanoR_1 | 283 | 289 | PF00244 | 0.582 |
LIG_14-3-3_CanoR_1 | 360 | 366 | PF00244 | 0.631 |
LIG_APCC_ABBA_1 | 308 | 313 | PF00400 | 0.528 |
LIG_APCC_ABBA_1 | 33 | 38 | PF00400 | 0.548 |
LIG_Clathr_ClatBox_1 | 399 | 403 | PF01394 | 0.401 |
LIG_CSL_BTD_1 | 224 | 227 | PF09270 | 0.408 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.432 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.482 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.617 |
LIG_FHA_1 | 160 | 166 | PF00498 | 0.377 |
LIG_FHA_1 | 233 | 239 | PF00498 | 0.426 |
LIG_FHA_1 | 252 | 258 | PF00498 | 0.382 |
LIG_FHA_1 | 273 | 279 | PF00498 | 0.402 |
LIG_FHA_1 | 362 | 368 | PF00498 | 0.582 |
LIG_FHA_2 | 210 | 216 | PF00498 | 0.622 |
LIG_LIR_Apic_2 | 112 | 116 | PF02991 | 0.247 |
LIG_LIR_Apic_2 | 8 | 12 | PF02991 | 0.640 |
LIG_LIR_Gen_1 | 30 | 39 | PF02991 | 0.606 |
LIG_LIR_Nem_3 | 223 | 228 | PF02991 | 0.342 |
LIG_LIR_Nem_3 | 251 | 256 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 30 | 36 | PF02991 | 0.581 |
LIG_LIR_Nem_3 | 333 | 337 | PF02991 | 0.282 |
LIG_LYPXL_yS_3 | 334 | 337 | PF13949 | 0.334 |
LIG_MYND_1 | 100 | 104 | PF01753 | 0.357 |
LIG_NRBOX | 302 | 308 | PF00104 | 0.430 |
LIG_PTB_Apo_2 | 398 | 405 | PF02174 | 0.423 |
LIG_SH2_CRK | 37 | 41 | PF00017 | 0.564 |
LIG_SH2_SRC | 153 | 156 | PF00017 | 0.482 |
LIG_SH2_SRC | 37 | 40 | PF00017 | 0.619 |
LIG_SH2_STAP1 | 37 | 41 | PF00017 | 0.529 |
LIG_SH2_STAT3 | 39 | 42 | PF00017 | 0.625 |
LIG_SH2_STAT5 | 130 | 133 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.482 |
LIG_SH2_STAT5 | 256 | 259 | PF00017 | 0.364 |
LIG_SH2_STAT5 | 267 | 270 | PF00017 | 0.283 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.557 |
LIG_SH2_STAT5 | 327 | 330 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.543 |
LIG_SH3_3 | 377 | 383 | PF00018 | 0.379 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.572 |
LIG_SH3_3 | 98 | 104 | PF00018 | 0.332 |
LIG_SH3_5 | 35 | 39 | PF00018 | 0.629 |
LIG_SUMO_SIM_anti_2 | 301 | 307 | PF11976 | 0.410 |
LIG_SUMO_SIM_anti_2 | 65 | 71 | PF11976 | 0.368 |
LIG_SUMO_SIM_par_1 | 65 | 71 | PF11976 | 0.368 |
LIG_TRFH_1 | 327 | 331 | PF08558 | 0.471 |
LIG_WRC_WIRS_1 | 110 | 115 | PF05994 | 0.374 |
MOD_CK1_1 | 112 | 118 | PF00069 | 0.300 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.335 |
MOD_CK1_1 | 234 | 240 | PF00069 | 0.417 |
MOD_CK1_1 | 251 | 257 | PF00069 | 0.548 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.484 |
MOD_CK1_1 | 8 | 14 | PF00069 | 0.595 |
MOD_CK2_1 | 209 | 215 | PF00069 | 0.389 |
MOD_CK2_1 | 86 | 92 | PF00069 | 0.547 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.603 |
MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.434 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.550 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.440 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.584 |
MOD_GSK3_1 | 159 | 166 | PF00069 | 0.321 |
MOD_GSK3_1 | 268 | 275 | PF00069 | 0.470 |
MOD_GSK3_1 | 294 | 301 | PF00069 | 0.401 |
MOD_GSK3_1 | 338 | 345 | PF00069 | 0.354 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.376 |
MOD_N-GLC_1 | 249 | 254 | PF02516 | 0.512 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.466 |
MOD_NEK2_1 | 164 | 169 | PF00069 | 0.329 |
MOD_NEK2_1 | 173 | 178 | PF00069 | 0.321 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.294 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.342 |
MOD_NEK2_1 | 220 | 225 | PF00069 | 0.344 |
MOD_NEK2_1 | 67 | 72 | PF00069 | 0.369 |
MOD_PIKK_1 | 102 | 108 | PF00454 | 0.441 |
MOD_PK_1 | 145 | 151 | PF00069 | 0.433 |
MOD_PKA_1 | 145 | 151 | PF00069 | 0.335 |
MOD_Plk_1 | 249 | 255 | PF00069 | 0.560 |
MOD_Plk_4 | 109 | 115 | PF00069 | 0.421 |
MOD_Plk_4 | 145 | 151 | PF00069 | 0.361 |
MOD_Plk_4 | 160 | 166 | PF00069 | 0.331 |
MOD_Plk_4 | 188 | 194 | PF00069 | 0.372 |
MOD_Plk_4 | 220 | 226 | PF00069 | 0.388 |
MOD_Plk_4 | 23 | 29 | PF00069 | 0.397 |
MOD_Plk_4 | 242 | 248 | PF00069 | 0.539 |
MOD_Plk_4 | 274 | 280 | PF00069 | 0.372 |
MOD_Plk_4 | 298 | 304 | PF00069 | 0.326 |
MOD_Plk_4 | 345 | 351 | PF00069 | 0.336 |
MOD_Plk_4 | 44 | 50 | PF00069 | 0.464 |
MOD_Plk_4 | 5 | 11 | PF00069 | 0.561 |
MOD_Plk_4 | 51 | 57 | PF00069 | 0.360 |
MOD_Plk_4 | 62 | 68 | PF00069 | 0.218 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.524 |
MOD_ProDKin_1 | 100 | 106 | PF00069 | 0.462 |
MOD_ProDKin_1 | 112 | 118 | PF00069 | 0.357 |
MOD_ProDKin_1 | 15 | 21 | PF00069 | 0.472 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.476 |
TRG_DiLeu_BaEn_2 | 199 | 205 | PF01217 | 0.355 |
TRG_DiLeu_BaLyEn_6 | 224 | 229 | PF01217 | 0.424 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.467 |
TRG_ENDOCYTIC_2 | 334 | 337 | PF00928 | 0.333 |
TRG_ENDOCYTIC_2 | 37 | 40 | PF00928 | 0.396 |
TRG_ER_diArg_1 | 257 | 259 | PF00400 | 0.477 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8V7 | Leptomonas seymouri | 63% | 95% |
A0A0S4J4C6 | Bodo saltans | 39% | 100% |
A0A1X0P7R6 | Trypanosomatidae | 48% | 99% |
A0A3Q8IJQ4 | Leishmania donovani | 94% | 100% |
A0A3R7N2B7 | Trypanosoma rangeli | 47% | 100% |
A4H9J2 | Leishmania braziliensis | 77% | 100% |
A4HXV5 | Leishmania infantum | 93% | 100% |
C9ZZU8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
E9ARL8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |